Leveraged loans - news in brief, August 8, 2014

drugs
By Ross Lancaster
07 Aug 2014

Huvepharma - Orion Engineered Carbons - Delek Group - Emsland – Stärke

Huvepharma finalising pricing on €275m acquisition loan

Bulgarian animal drugs firm Huvepharma is set to announce a final price structure on its €275m acquisition loan.

Moody’s and Standard & Poor’s made their ratings later than expected, with the result that the borrower’s ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial